Skip to main content

Maria Cristina Centeno Mediavilla

Institutions of which they are part

Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Maria Cristina Centeno Mediavilla

Institutions of which they are part

Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Targeting Myeloid-Derived Suppressor Cells to prevent HIV/STI acquisition

IP: Meritxell Genesca Ferrer
Collaborators: Maria Cristina Centeno Mediavilla, Nuria Laia Rodriguez Mias, Yannick Hoyos Mallecot, Josep Castellví Vives, Laura Mañalich Barrachina, María José Buzón Gómez, Maider Arando Lasagabaster, Targeting Myeloid-Derived Suppressor Cells to prevent HIV/STI acquisition, Bibiana Planas Ribas, Cristina Mancebo Perez
Funding agency: Fundació La Marató de TV3
Funding: 199685
Reference: 20181410
Duration: 10/05/2019 - 31/12/2022

Caracterización de los reservorios VIH latentes del tejido cervical y nuevas estrategias para eliminarlos

IP: Meritxell Genesca Ferrer
Collaborators: Vicenç Falcó Ferrer, Maria Cristina Centeno Mediavilla
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI17/01470
Duration: 01/01/2018 - 31/12/2021

Desarrollo de una herramienta de diagnóstico precoz de cáncer de endometrio en biopsia líquida cervical

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Maria Cristina Centeno Mediavilla, Silvia Franco Camps, Silvia Cabrera Diaz
Funding agency: Instituto de Salud Carlos III
Funding: 93170
Reference: PI17/02155
Duration: 01/01/2018 - 30/06/2022

STELLA trial: Ensayo clínico randomizado comparando la via de abordaje de la linfadenectomía aórtica laparoscópica: via transperitoneal vs extraperitoneal en cáncer de endometrio y ovario

IP: Berta Diaz Feijoo
Collaborators: Maria Cristina Centeno Mediavilla, Fco Javier De la Torre Fdez de Vega, Silvia Franco Camps, Montserrat Cubo Abert
Funding agency: Instituto de Salud Carlos III
Funding: 36905
Reference: PI14/01817
Duration: 01/01/2015 - 30/06/2019

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Alba Mir Cros

Alba Mir Cros

Postdoctoral researcher
Microbiology
Read more
Pedro Alejandro Gil Millán

Pedro Alejandro Gil Millán

Predoctoral researcher
Diabetes and Metabolism
Read more
Gabriel Sampol Rubio

Gabriel Sampol Rubio

Pneumology
Read more
Javier Lopez-Ibañez Infante

Javier Lopez-Ibañez Infante

Tècnic/a Superior Recerca
Statistics and Bioinformatics Unit (UEB)
Preclinical Core Facilities
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.